T. Vanlaar et al., THE ROLE OF EDTA IN PROVOKING ALLERGIC REACTIONS TO SUBCUTANEOUS INFUSION OF APOMORPHINE IN PATIENTS WITH PARKINSONS-DISEASE - A HISTOLOGIC-STUDY, Movement disorders, 13(1), 1998, pp. 52-55
One of the formulations of apomorphine. used in clinical practice, con
tains sodium edetate (EDTA). EDTA is a chelator which indirectly preve
nts oxidation of apomorphine. A clinical and histologic study in four
patients revealed that apomorphine with EDTA caused severe subcutaneou
s nodules, histologically characterized by an inflammatory infiltrate
with a large amount of eosinophils, indicating a cell-mediated allergi
c reaction. After withdrawal of EDTA. this allergic component complete
ly disappeared, which was accompanied clinically by less extensive nod
ule formation with a softer consistency. It is therefore recommended t
hat EDTA be excluded from apomorphine formulations.